Sign inGet started

DWTX

Dogwood Therapeutics, Inc.CIK 1818844 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
11

AI insights for DWTX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for DWTX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Sealbond LtdDirector, 10% Owner, Other1$0$02026-10-26
Keefer David RDirector4$0$02026-06-16
De La Rosa AbelDirector4$0$02026-06-16
Whitley Richard JamesDirector4$0$02026-06-16
Thomas John CDirector4$0$02026-06-16
Duncan Gregory ScottCHIEF EXECUTIVE OFFICER3$0$02026-03-05
Gendreau Roger MichaelCHIEF MEDICAL OFFICER3$0$02026-03-05
Grosswald RalphSVP OF OPERATIONS3$0$02026-03-05
Walsh AngelaChief Financial Officer3$0$02026-03-05
Conjoint Inc.Director, 10% Owner4$0$02025-11-21
CK Life Sciences Intl (Holdings) IncDirector, 10% Owner1$0$02025-03-12

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Sealbond LtdDirector, 10% Owner, Other A Award2026-10-262026-10-274,098,360$1.22 $5.00M25,920,693SEC↗
Keefer David RDirector A Award deriv2026-06-162026-06-1716,800— $016,800SEC↗
Whitley Richard JamesDirector A Award deriv2026-06-162026-06-1716,800— $016,800SEC↗
Thomas John CDirector A Award deriv2026-06-162026-06-1716,800— $016,800SEC↗
De La Rosa AbelDirector A Award deriv2026-06-162026-06-1716,800— $016,800SEC↗
Duncan Gregory ScottCHIEF EXECUTIVE OFFICER A Award deriv2026-03-052026-03-06330,000— $0330,000SEC↗
Gendreau Roger MichaelCHIEF MEDICAL OFFICER A Award deriv2026-03-052026-03-0682,500— $082,500SEC↗
Walsh AngelaChief Financial Officer A Award deriv2026-03-052026-03-0682,500— $082,500SEC↗
Grosswald RalphSVP OF OPERATIONS A Award deriv2026-03-052026-03-0682,500— $082,500SEC↗
Gendreau Roger MichaelCHIEF MEDICAL OFFICER A Award deriv2025-12-042025-12-05150,000— $0150,000SEC↗
Grosswald RalphSVP OF OPERATIONS A Award deriv2025-12-042025-12-05150,000— $0150,000SEC↗
Walsh AngelaChief Financial Officer A Award deriv2025-12-042025-12-05150,000— $0150,000SEC↗
Duncan Gregory ScottCHIEF EXECUTIVE OFFICER A Award deriv2025-12-042025-12-05460,000— $0460,000SEC↗
Conjoint Inc.Director, 10% Owner C Conversion deriv2025-11-212025-11-252,161— $00SEC↗
Conjoint Inc.Director, 10% Owner C Conversion deriv2025-11-212025-11-25284— $00SEC↗
Conjoint Inc.Director, 10% Owner C Conversion2025-11-212025-11-2521,610,950— $021,822,333SEC↗
Conjoint Inc.Director, 10% Owner C Conversion2025-11-212025-11-252,842,638— $02,842,638SEC↗
De La Rosa AbelDirector A Award deriv2025-06-272025-07-012,362— $02,362SEC↗
Walsh AngelaChief Financial Officer A Award deriv2025-06-272025-07-0112,075— $012,075SEC↗
Keefer David RDirector A Award deriv2025-06-272025-07-012,362— $02,362SEC↗
Duncan Gregory ScottCHIEF EXECUTIVE OFFICER A Award deriv2025-06-272025-07-0140,000— $040,000SEC↗
Thomas John CDirector A Award deriv2025-06-272025-07-012,362— $02,362SEC↗
Grosswald RalphSVP OF OPERATIONS A Award deriv2025-06-272025-07-0112,075— $012,075SEC↗
Whitley Richard JamesDirector A Award deriv2025-06-272025-07-012,362— $02,362SEC↗
Gendreau Roger MichaelCHIEF MEDICAL OFFICER A Award deriv2025-06-272025-07-0112,075— $012,075SEC↗
De La Rosa AbelDirector A Award deriv2025-06-182025-06-23210— $0210SEC↗
De La Rosa AbelDirector A Award deriv2025-06-182025-06-23210— $0420SEC↗
Thomas John CDirector A Award deriv2025-06-182025-06-23210— $0210SEC↗
Thomas John CDirector A Award deriv2025-06-182025-06-23210— $0420SEC↗
Keefer David RDirector A Award deriv2025-06-182025-06-23210— $0420SEC↗
Keefer David RDirector A Award deriv2025-06-182025-06-23210— $0210SEC↗
Whitley Richard JamesDirector A Award deriv2025-06-182025-06-23210— $0210SEC↗
Whitley Richard JamesDirector A Award deriv2025-06-182025-06-23210— $0420SEC↗
CK Life Sciences Intl (HoldingDirector, 10% Owner A Award deriv2025-03-122025-03-17284$7.01 $2.0K284SEC↗